You have 9 free searches left this month | for more free features.

Angiofibroma

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Juvenile Nasopharyngeal Angiofibroma Trial in Moscow (Sirolimus)

Recruiting
  • Juvenile Nasopharyngeal Angiofibroma
  • Moscow, Russian Federation
    Research Institute of Pediatric Hematology, Oncology and Immunol
Sep 19, 2022

Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )

Completed
  • Facial Angiofibroma
  • Tuberous Sclerosis
  • Phoenix, Arizona
  • +16 more
Jul 26, 2022

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Active, not recruiting
  • Hypomelanotic Macules
  • +8 more
    • Tirana, Albania
    • +7 more
    Mar 23, 2022

    Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)

    Recruiting
    • Angiofibroma of Face
    • Tuberous Sclerosis
    • Sirolimus 0.2%
    • +2 more
    • Phoenix, Arizona
    • +7 more
    Feb 2, 2022

    Squamous Cell Carcinoma of the Head and Neck, Nasopharyngeal Carcinoma, Salivary Gland Cancer Trial in Saint Louis (stereotactic

    Completed
    • Squamous Cell Carcinoma of the Head and Neck
    • +7 more
    • stereotactic body radiotherapy
    • Stereotactic body radiotherapy
    • Saint Louis, Missouri
      St. John's Mercy Medical Center
    Mar 28, 2020

    Angiofibromas, Tuberous Sclerosis Trial in Australia, United States (Placebo, Rapamycin)

    Completed
    • Angiofibromas
    • Tuberous Sclerosis
    • Birmingham, Alabama
    • +9 more
    Sep 30, 2020

    Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)

    Recruiting
    • Tuberous Sclerosis Complex
    • NPC-12Y gel
    • NPC-12Y placebo gel
    • Toyoake, Aichi, Japan
    • +4 more
    Aug 8, 2022

    Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule Trial in Suita, Osaka (NPC-12G gel)

    Completed
    • Tuberous Sclerosis
    • +3 more
    • NPC-12G gel
    • Suita, Osaka, Japan
      Graduate School of Medicine, Osaka University
    Feb 18, 2019

    Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

    Recruiting
    • Tuberous Sclerosis
    • Lymphangioleiomyomatosis
    • Phlebotomy
    • +3 more
    • Birmingham, Alabama
    • +22 more
    Jan 6, 2023

    Facial Angiofibroma Trial (Rapamycin, Calcitriol, Rapamycin-calcitriol combination)

    Completed
    • Facial Angiofibroma
    • (no location specified)
    May 2, 2017

    Dengue, Dengue Fever, Dengue Hemorrhagic Fever Trial in Worldwide (Live, attenuated, dengue serotype 1, 2, 3, 4 virus, Placebo:

    Completed
    • Dengue
    • +2 more
    • Live, attenuated, dengue serotype 1, 2, 3, 4 virus
    • Placebo: Sodium chloride (NaCl) 0.9%
    • Denpasar, Bali, Indonesia
    • +11 more
    Mar 10, 2022

    Tuberous Sclerosis, Angiofibroma, Hypomelanotic Macule Trial in Suita, Osaka (NPC-12G gel, Placebo gel)

    Completed
    • Tuberous Sclerosis
    • +3 more
    • NPC-12G gel
    • Placebo gel
    • Suita, Osaka, Japan
      Graduate School of Medicine, Osaka University
    Feb 1, 2017

    Facial Angiofibroma Trial in Memphis (Rapamune)

    Completed
    • Facial Angiofibroma
    • Memphis, Tennessee
      LeBonheur Children's Hospital
    Aug 17, 2016

    Coronary Artery Disease Trial in Ferrara, London (Ivabradine, Placebo)

    Completed
    • Coronary Artery Disease
    • Ferrara, Italy
    • +1 more
    Mar 2, 2020

    Food Allergy Trial in New York (Partially Hydrolyzed Whey formula)

    Completed
    • Food Allergy
    • Partially Hydrolyzed Whey formula
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    Dec 6, 2016

    (NCGS): A Post-marketing Surveillance Program for Nutropin,

    Completed
    • Growth Disorders
    • Somatrem
    • Somatropin
    • (no location specified)
    Dec 21, 2016

    Fabry Disease Trial in Copenhagen (Enzyme replacement)

    Completed
    • Fabry Disease
    • Enzyme replacement
    • Copenhagen, Capital region, Denmark
    • +1 more
    Oct 26, 2014

    Hyperpigmentation Trial in Boston (Nu Skin Product, Cosmetic instrument, Tretinoin cream 0.05)

    Completed
    • Hyperpigmentation
    • Nu Skin Product
    • +3 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Oct 30, 2014

    Tuberous Sclerosis, Neurofibromatoses, Angiofibroma Trial in Houston (Skincerity, Skincerity plus sirolimus/rapamycin,

    Completed
    • Tuberous Sclerosis
    • +3 more
    • Houston, Texas
      The University of Texas Health Science Center
    Feb 24, 2012